Abstracts 1978
DOI: 10.1016/b978-0-08-023768-8.51049-5
|View full text |Cite
|
Sign up to set email alerts
|

The Pharmacokinetics of Long Acting Propranolol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

1982
1982
1982
1982

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…A peripheral bolus (0.5 mg/kg) of P was followed by portal infusion (8.0 pg/kg per min). H3-Propranolol (H3-P) was given as a peripheral bolus (2 pCi/kg) and infusion (12.1 nCi/kg per rnin) as was DPH (7. Previous studies have shown that long-acting propranolol (LA) produces lower mean peak concentrations of propranolol in plasma and has a longer mean time to peak than conventional (CP) propranolol (McAinsh et al, 1978). We have investigated the pharmacokinetics of both propranolol (P) and 4-hydroxypropranolol(4HP) in ten healthy subjects and report the results after 4 days of treatment with either 320 mg/day of LA or CP.…”
Section: Interaction Betweenmentioning
confidence: 99%
“…A peripheral bolus (0.5 mg/kg) of P was followed by portal infusion (8.0 pg/kg per min). H3-Propranolol (H3-P) was given as a peripheral bolus (2 pCi/kg) and infusion (12.1 nCi/kg per rnin) as was DPH (7. Previous studies have shown that long-acting propranolol (LA) produces lower mean peak concentrations of propranolol in plasma and has a longer mean time to peak than conventional (CP) propranolol (McAinsh et al, 1978). We have investigated the pharmacokinetics of both propranolol (P) and 4-hydroxypropranolol(4HP) in ten healthy subjects and report the results after 4 days of treatment with either 320 mg/day of LA or CP.…”
Section: Interaction Betweenmentioning
confidence: 99%